Cargando…

Loss of Fingerprints as a Side Effect of Capecitabine Therapy: Case Report and Literature Review

Hand–foot syndrome (HFS) is the main side effect of capecitabine and affects the compression zones of the body such as the palms and soles, causing numbness, paresthesias, skin swelling or erythema, scaling, chapping, hard nodule-like blisters, and severe pain. Loss of fingerprints is also observed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jian, Zhang, Xia, Cui, Xiaonan, Wang, Di, Zhang, Bin, Ban, Liying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2020
Materias:	Case Report/Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851501/ https://www.ncbi.nlm.nih.gov/pubmed/31558182 http://dx.doi.org/10.3727/096504019X15605078731913

Ejemplares similares

Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine
por: Cohen, Philip R
Publicado: (2017)

Temozolomide Combined With Capecitabine In The Treatment Of Mixed Neuroendocrine Carcinoma Of The Lung With Poor Tolerance After Repeated Radiochemotherapy: A Case Report And Literature Review
por: Zhang, Bin, et al.
Publicado: (2019)

Capecitabine-Associated Loss of Fingerprints: A Case Report of a 62-Year-Old Man With Colorectal Cancer Suffering From Capecitabine-Induced Adermatoglyphia
por: Dawood, Tasneem, et al.
Publicado: (2021)

Capecitabine-induced cardiotoxicity: case report and review of the literature
por: Ang, C., et al.
Publicado: (2010)

Oromandibular dystonia: a serious side effect of capecitabine
por: van Pelt-Sprangers, Melanie JM, et al.
Publicado: (2015)

Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review
por: Klimko, Artsiom, et al.
Publicado: (2021)

Efficacy and Side Effects of Combined Capecitabine Plus Intensity Modulated Radiotherapy as an Effective Adjuvant Therapy for Gastric Cancers
por: Fu, Jie, et al.
Publicado: (2020)

PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature
por: Wang, Zhihong, et al.
Publicado: (2021)

Capecitabine and Warfarin Interaction: A Case Report With Review of Literature and Management Options
por: Althiab, Khalefa, et al.
Publicado: (2022)

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
por: Derakhshani, Afshin, et al.
Publicado: (2021)

Severe Hemorrhagic Cystitis Caused by Cyclophosphamide and Capecitabine Therapy in Breast Cancer Patients: Two Case Reports and Literature Review
por: Tanaka, Toshihiro, et al.
Publicado: (2019)

Comparison of apatinib and capecitabine (Xeloda) with capecitabine (Xeloda) in advanced triple-negative breast cancer as third-line therapy: A retrospective study
por: Li, Yi-Hui, et al.
Publicado: (2018)

Case Report: Vision Loss Induced by Capecitabine in Patient with Preexisting Left Eyes Blind
por: Matte, Paul, et al.
Publicado: (2023)

Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review
por: Ishida, Atsushi, et al.
Publicado: (2022)

Raltitrexed as a substitute for capecitabine in metastatic gastric cancer: a case report and literature review
por: Ladak, Imran, et al.
Publicado: (2022)

Drug-Induced Liver Injury Caused by Capecitabine: A Case Report and a Literature Review
por: Hussein, Miriam, et al.
Publicado: (2023)

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients
por: LIANG, XU, et al.
Publicado: (2015)

Report on short-term side effects of treatments with (177)Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours
por: van Essen, Martijn, et al.
Publicado: (2008)

Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer
por: Kawakami, Kazuyoshi, et al.
Publicado: (2017)

Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature
por: Bongiovanni, Alberto, et al.
Publicado: (2014)

Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review
por: Maur, Michela, et al.
Publicado: (2017)

Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review
por: Hagiwara, Yuya, et al.
Publicado: (2022)

Hepatoid adenocarcinoma of the stomach effectively treated with capecitabine with oxaliplatin as adjuvant chemotherapy: A case report and literature review
por: Amioka, Jun, et al.
Publicado: (2023)

A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
por: Lu, Zhihao, et al.
Publicado: (2018)

Clinical Effect of Radiotherapy Combined with Capecitabine after Neoadjuvant Therapy for Rectal Cancer
por: Zhang, Qibo, et al.
Publicado: (2021)

A Case of Capecitabine-Induced Sarcoidosis
por: Kang, Shin Myung, et al.
Publicado: (2012)

Serial renography for evaluation of the impact of capecitabine therapy on renal function: A case report
por: Ren, Jiazhong, et al.
Publicado: (2017)

Capecitabine-induced Leukoencephalopathy
por: Yoshimura, Kenji, et al.
Publicado: (2018)

Capecitabine-Induced Enterocolitis
por: Khan, Muzammil, et al.
Publicado: (2022)

Retrospective study of preoperative chemoradiotherapy with capecitabine versus capecitabine plus oxaliplatin for locally advanced rectal cancer
por: Yang, Xiao-Hui, et al.
Publicado: (2020)

Hepatic steatosis secondary to capecitabine: a case report
por: Chin, Sheray N, et al.
Publicado: (2010)

Concurrent capecitabine and upper abdominal radiation therapy is well tolerated
por: Das, Prajnan, et al.
Publicado: (2006)

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
por: Si, W., et al.
Publicado: (2013)

Concomitant (177)Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
por: Yadav, Madhav Prasad, et al.
Publicado: (2019)

Spontaneous coronary artery dissection during cisplatin and capecitabine therapy
por: Somov, Pavel, et al.
Publicado: (2019)

Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
por: Rhee, Jiyoung, et al.
Publicado: (2019)

Bevacizumab Combined With Oxaliplatin/Capecitabine in Patient With Refractory and Recurrent Mucinous Adenocarcinoma of the Appendix: A Case Report
por: Liu, Wenzhi, et al.
Publicado: (2019)

Primary renal carcinoid tumor: case report and review of the literature
por: Li, Bin, et al.
Publicado: (2016)

Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome – A literature review()
por: Nascimento, Anna Danielly Almeida do, et al.
Publicado: (2023)

Pediatric pancreatic teratoma: A case report and literature review
por: Wang, Jian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0l3snjomo4u77tg91vcb5tp2uj